CN219097043U

CN219097043U - Medicine split charging system

Info

Publication number: CN219097043U
Application number: CN202222932387.7U
Authority: CN
Inventors: 虞善友; 吕璇; 樊煜; 颜成龙; 方鹏
Original assignee: Wuxi Nuoyu Pharmaceutical Technology Co ltd
Current assignee: Wuxi Tongmao Medical Technology Co ltd
Priority date: 2022-11-02
Filing date: 2022-11-02
Publication date: 2023-05-30
Anticipated expiration: 2032-11-02

Abstract

The utility model discloses a medicine split charging system, which comprises: a drug delivery assembly comprising a first drug delivery member adapted to be inserted into or withdrawn from a drug storage member for containing a drug, the first drug delivery member being in communication with the multi-pass member, the multi-pass member further adapted to be in communication with the dispensing container for communication with the multi-pass member and the dispensing container; the split charging device is arranged on the drug conveying assembly, the split charging device is used for driving the first drug conveying piece to insert or pull out the drug storage piece, and the split charging device is also used for driving the drug in the drug storage piece to flow into the split charging container along the first drug conveying piece and the multi-way piece. Therefore, the medicine can be automatically packaged into the packaging containers through the matching of the medicine conveying component and the packaging device, compared with the prior art, the time for workers to contact the radioactive medicine is reduced, the radiation dose infection is reduced, and the radioactive injury of the medicine to the workers is reduced.

Description

Medicine split charging system

Technical Field

The utility model relates to the field of split charging equipment, in particular to a medicine split charging system.

Background

In recent years, drugs for tumor diagnosis and treatment have been rapidly developed, and emerging radionuclide-containing drugs are growing, and radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. A compound or biological agent containing a radionuclide label for use in medical diagnosis or therapy in vivo. Due to the high penetration photons emitted by these radionuclides, it may be possible for the operator to be subjected to high radiation doses during the drug synthesis process.

At present, medical radiopharmaceuticals are widely used in clinic, most of hospital institutions adopt manual operation in the process of sub-packaging the radiopharmaceuticals, firstly medical staff wear protective clothing, then hold a syringe to put in a radiation-proof reagent bottle to take out the radiopharmaceuticals, the radiopharmaceuticals are pumped into the syringe through the syringe and then sequentially injected into a plurality of smaller radiation-proof reagent bottles, and finally the bottle stopper is plugged tightly, so that sub-packaging of the radiopharmaceuticals is completed. But such an operation wastes a lot of time and makes the work efficiency low. Meanwhile, staff can contact the radiopharmaceuticals for a long time in operation, so that radiation dose infection is increased, and radioactive injury is easily caused to related staff.

Disclosure of Invention

The present utility model aims to solve at least one of the technical problems existing in the prior art. Therefore, an object of the present utility model is to provide a medicine dispensing system capable of automatically dispensing medicine into dispensing containers, thereby reducing the radioactive injury of the medicine to staff.

The medicament dispensing system according to the present utility model comprises:

a drug delivery assembly comprising a first drug delivery member adapted to be inserted into or withdrawn from a drug storage member for containing a drug, and a multi-way member in communication with the multi-way member, the multi-way member further adapted to be in communication with a dispensing container to communicate the multi-way member with the dispensing container;

The split charging device is used for driving the first medicine conveying piece to be inserted into or pulled out of the medicine storage piece, and the split charging device is also used for driving medicine in the medicine storage piece to flow into the split charging container along the first medicine conveying piece and the multi-way piece.

According to the medicine split charging system, the medicine can be automatically split charged into the split charging container through the matching of the medicine conveying component and the split charging device, compared with the prior art, the time for workers to contact with the radioactive medicine is reduced, the radiation dose infection is reduced, and the radioactive injury of the medicine to the workers is reduced.

In some examples of the present utility model, the multi-way member has a first drug inlet, a second drug inlet, and a drug outlet, the drug outlet is in communication with both the first drug inlet and the second drug inlet, the first drug inlet is in communication with the first drug delivery member via a first conduit, and the second drug inlet is in communication with a second conduit.

In some examples of the utility model, the dispensing device comprises: the first split charging mechanism is provided with a first shell and a first driving assembly, the first driving assembly is arranged on the first shell and is connected with the first medicine conveying piece, and the first driving assembly is used for driving the first medicine conveying piece to move so that the first medicine conveying piece can be inserted into or pulled out of the medicine storage piece.

In some examples of the utility model, the first drive assembly includes: remove seat and first driving piece, first driving piece with remove seat transmission connection with the drive remove the seat relative first casing removes, drug delivery assembly still includes the mounting panel, first drug delivery piece install in the mounting panel, mounting panel detachably install in remove the seat.

In some examples of the utility model, the mobile station has a slot within which the mounting plate is mounted.

In some examples of the utility model, the inner side wall of the slot is provided with a stop for stopping the mounting plate.

In some examples of the utility model, the drug delivery assembly further comprises an air pressure balance member provided to the mounting plate and adapted to insert or withdraw the drug storage member, the air pressure balance member being adapted to communicate the drug storage member with an external atmosphere.

In some examples of the utility model, the mounting plate is provided with a filter in communication with the air pressure balance.

In some examples of the utility model, the first housing has a receiving cavity for receiving the drug storage member, the receiving cavity being opposite the first drug delivery member.

In some examples of the utility model, a first radiation detecting element is disposed within the receiving cavity.

In some examples of the utility model, a heating element and/or a heat sink is provided within the receiving chamber.

In some examples of the utility model, the racking device further comprises: the second split charging mechanism is provided with a second shell, a first peristaltic pump and a second peristaltic pump, the first peristaltic pump and the second peristaltic pump are arranged on the outer surface of the second shell, the first pipeline is arranged in a first extrusion groove of the first peristaltic pump, and the second pipeline is arranged in a second extrusion groove of the second peristaltic pump.

In some examples of the present utility model, the second dispensing mechanism further has a fixing assembly and a second driving assembly, the fixing assembly and the second driving assembly are both provided to the second housing, the fixing assembly is used for placing the dispensing container, the second driving assembly is used for placing the multi-way member, and the second driving assembly is suitable for driving the multi-way member to move towards or away from the dispensing container so as to enable the medicine outlet to be communicated with the dispensing container or enable the medicine outlet to be separated from the dispensing container.

In some examples of the utility model, the second drive assembly includes: the mounting seat is provided with a fixing groove for mounting the multi-way part, the mounting seat is in transmission connection with the second driving part, and the second driving part is suitable for driving the mounting seat to move towards or away from the sub-packaging container.

In some examples of the utility model, the securing assembly includes: a shielding shell and a fixed block, wherein the shielding shell defines a shielding space for accommodating the sub-packaging container, and the shielding shell is provided with a first through hole communicated with the shielding space;

the fixed block is provided with a placing groove for placing the shielding shell, the fixed block is further provided with a mounting groove, a second radioactivity detecting piece is arranged in the mounting groove, and the first through hole is communicated with the mounting groove and the shielding space when the shielding shell is placed in the placing groove.

In some examples of the utility model, the first through hole and/or the open end of the mounting groove is provided with lead glass.

In some examples of the present utility model, the drug dispensing system further comprises: a synthesis device for synthesizing a radiopharmaceutical and adapted to deliver the radiopharmaceutical into the drug reservoir.

In some examples of the utility model, the synthesizing device includes a rinse bottle, a nuclide generator, a three-way valve having a first valve port in communication with the rinse bottle, a second valve port in communication with the syringe, and a third valve port in communication with a generator inlet of the nuclide generator, and a generator outlet of the nuclide generator adapted to communicate with the drug storage.

In some examples of the utility model, the synthesizing apparatus further comprises: the third driving assembly is arranged on the third shell and connected with the syringe piston of the syringe to drive the syringe piston to move.

Additional aspects and advantages of the utility model will be set forth in part in the description which follows, and in part will be obvious from the description, or may be learned by practice of the utility model.

Drawings

The foregoing and/or additional aspects and advantages of the utility model will become apparent and may be better understood from the following description of embodiments taken in conjunction with the accompanying drawings in which:

FIG. 1 is a schematic illustration of a drug dispensing system according to an embodiment of the present utility model;

FIG. 2 is a schematic view of an assembly of a dispensing device and a drug delivery assembly according to an embodiment of the present utility model;

FIG. 3 is a schematic view of a first racking mechanism according to an embodiment of the utility model;

FIG. 4 is a schematic diagram of an assembly of a mobile seat and a mounting plate according to an embodiment of the utility model;

FIG. 5 is a schematic view of a first embodiment of a drug delivery assembly according to an embodiment of the present utility model;

FIG. 6 is a schematic view of a second embodiment of a drug delivery assembly according to an embodiment of the present utility model;

FIG. 7 is a schematic diagram of a multipass member according to an embodiment of the present utility model;

FIG. 8 is a schematic view of an assembly of a mounting plate, a first drug delivery member, an air pressure balance member, and a filter member according to an embodiment of the present utility model;

FIG. 9 is a schematic view of a second racking mechanism according to an embodiment of the utility model;

FIG. 10 is another angular schematic view of a second racking mechanism according to an embodiment of the utility model;

FIG. 11 is a schematic illustration of the engagement of a stationary assembly and a second drive assembly according to an embodiment of the present utility model;

FIG. 12 is a top plan view of a stationary assembly and a second drive assembly mated in accordance with an embodiment of the present utility model;

FIG. 13 is a cross-sectional view taken at A-A of FIG. 12;

fig. 14 is a schematic view of an assembly of a shield shell and a racking container according to an embodiment of the utility model;

Fig. 15 is a front view of a shield shell according to an embodiment of the present utility model;

FIG. 16 is a cross-sectional view taken at B-B of FIG. 15;

FIG. 17 is a cross-sectional view taken at C-C of FIG. 15;

fig. 18 is a schematic view of a shield shell according to an embodiment of the present utility model;

FIG. 19 is a schematic view of a fixed block according to an embodiment of the present utility model;

FIG. 20 is a top view of a securing block according to an embodiment of the present utility model;

FIG. 21 is a cross-sectional view taken at D-D of FIG. 20;

FIG. 22 is a schematic diagram of a synthesizing apparatus according to an embodiment of the present utility model;

fig. 23 is a front view of a synthesizing apparatus according to an embodiment of the present utility model;

FIG. 24 is a cross-sectional view taken at E-E of FIG. 23.

Reference numerals:

a drug dispensing system 100;

a drug delivery assembly 10; a first drug delivery member 11;

a multipass member 12; a first medicine inlet 121; a second inlet 122; a medicine outlet 123; a first conduit 124; a second line 125;

a mounting plate 13; a pneumatic balance 14; a filter 15; a stopper 16;

a dispensing device 20;

a first dispensing mechanism 21; a first housing 211; a moving seat 213; a slot 215; a receiving chamber 216; a guide hole 217; a first notch 218; a second notch 219;

a second split charging mechanism 30; a second housing 31; a first peristaltic pump 32; a second peristaltic pump 33; a first pressing groove 34; a second pressing groove 35;

A securing assembly 36; a shielding case 361;

a fixed block 362; a first sub-mount 3621; a second sub-mount 3622; a second through hole 3623;

a shielding space 363; a first through hole 364; a placement groove 365; a mounting slot 366; lead glass 368; a rotating cover 369;

a second drive assembly 37; a mounting base 371; a fixing groove 373; a drive motor 374; a lead screw 375; a slider 376;

a synthesizing device 40; a shower bottle 41;

a nuclide generator 42; generator inlet 421; a generator outlet 422;

a three-way valve 43; a first valve port 431; a second valve port 432; a third valve port 433;

a syringe 44; a syringe piston 441;

a third housing 45;

a third drive assembly 46; a driving block 461; a screw 462; a screw 463;

a third line 50; a fourth line 60; a fifth line 70;

a drug storage member 200; a sub-packaging container 300; and a storage container 400.

Detailed Description

Embodiments of the present utility model are described in detail below, examples of which are illustrated in the accompanying drawings, wherein like or similar reference numerals refer to like or similar elements or elements having like or similar functions throughout. The embodiments described below by referring to the drawings are illustrative only and are not to be construed as limiting the utility model.

A drug dispensing system 100 according to an embodiment of the present utility model is described below with reference to fig. 1-24, in which the drug dispensing system 100 is used to dispense a drug, which may be a liquid drug, and the present application is described with reference to the use of the drug dispensing system 100 to dispense a radiopharmaceutical (i.e., a nuclear medicine). The drug dispensing system 100 may also be used to dilute a radiopharmaceutical.

As shown in fig. 2 to 8, the medicine dispensing system 100 according to the embodiment of the present utility model includes: a drug delivery assembly 10 and a dispensing device 20. The drug delivery assembly 10 comprises a first drug delivery member 11 and a multi-way member 12, wherein the first drug delivery member 11 can be of a hollow tubular structure, the first drug delivery member 11 can be provided as a contact pin, the first drug delivery member 11 is suitable for being inserted into or pulled out of a drug storage member 200 for containing a drug, the drug storage member 200 can be a drug storage bottle or a drug storage tank, the first drug delivery member 11 can be inserted into or pulled out of the drug storage member 200 through a cover body (which can be a rubber plug) of the drug storage member 200, and the first drug delivery member 11 can be inserted into the bottom wall of the drug storage member 200. The first drug delivery member 11 communicates with the multi-pass member 12, the multi-pass member 12 is further adapted to communicate with the sub-container 300 to communicate the multi-pass member 12 with the sub-container 300, and it is also understood that the multi-pass member 12 is adapted to communicate with both the first drug delivery member 11 and the sub-container 300, and the multi-pass member 12 communicates with the first drug delivery member 11 and the sub-container 300. The drug delivery assembly 10 is disposed in the split charging device 20, and it should be noted that at least a part of the structure of the drug delivery assembly 10 is disposed in the split charging device 20, the split charging device 20 is used for driving the first drug delivery member 11 to insert into or extract from the drug storage member 200, and the split charging device 20 is used for directly or indirectly driving the first drug delivery member 11 to insert into or extract from the drug storage member 200. The dispensing device 20 is further used for driving the medicine in the medicine storage part 200 to flow into the dispensing container 300 along the first medicine conveying part 11 and the multi-way part 12, and it should be noted that the dispensing device 20 can drive the medicine conveying assembly 10 to act to enable the first medicine conveying part 11 to suck the medicine in the medicine storage part 200 so as to enable the medicine in the medicine storage part 200 to flow into the dispensing container 300 along the first medicine conveying part 11 and the multi-way part 12, or the dispensing device 20 can pump the medicine in the medicine storage part 200 into the first medicine conveying part 11 so as to enable the medicine in the medicine storage part 200 to flow into the dispensing container 300 along the first medicine conveying part 11 and the multi-way part 12, so as to realize the dispensing of the radioactive medicine.

When the medicine split charging system 100 is used for split charging medicine, the medicine storage piece 200 is placed at a position opposite to the first medicine delivery piece 11, the split charging device 20 drives the first medicine delivery piece 11 to move towards the medicine storage piece 200, so that the first medicine delivery piece 11 is inserted into the medicine storage piece 200, the multi-way piece 12 is communicated with the first medicine delivery piece 11 and the split charging container 300, the split charging device 20 drives the medicine in the medicine storage piece 200 to flow into the split charging container 300 along the first medicine delivery piece 11 and the multi-way piece 12, the medicine is split into the split charging container 300, and a worker can take the split charging container 300 to a room of a patient needing to be injected with the radioactive medicine. Through using the medicine sub-packaging system 100 sub-packaging medicine of this application for need not again manual operation after medicine storage piece 200 is placed in the position relative with first medicine delivery piece 11 and absorb the radiopharmaceutical, reduced the direct contact of medicine and staff, reduce the contact of staff and radioactive radiation, reduced the time of operating personnel contact medicine, reduced the radiation dose and infected, reduce the radioactive injury that the medicine caused to the staff, and medicine sub-packaging system 100 can accomplish the sub-packaging of medicine voluntarily, convenient and fast has saved a large amount of sub-packaging time, has promoted sub-packaging medicine efficiency, greatly reduced staff work load.

Thus, by the cooperation of the drug delivery assembly 10 and the dispensing device 20, the drug can be automatically dispensed into the dispensing container 300, reducing the time for the staff to contact the radiopharmaceutical, reducing the radiation dose infection, and reducing the radioactive injury of the drug to the staff as compared with the prior art.

In some embodiments of the present utility model, as shown in fig. 5-7, the multi-pass element 12 has a first drug inlet 121, a second drug inlet 122, and a drug outlet 123, the drug outlet 123 is in communication with both the first drug inlet 121 and the second drug inlet 122, the first drug inlet 121 is in communication with the first drug delivery element 11 via a first conduit 124, the first conduit 124 is in communication with the first drug inlet 121 and the first drug delivery element 11, and the second drug inlet 122 is in communication with a second conduit 125. Wherein, one end of the first pipeline 124 is communicated with the first medicine delivery member 11, the other end of the first pipeline 124 is communicated with the first medicine inlet 121, one end of the second pipeline 125 is communicated with the second medicine inlet 122, the other end of the second pipeline 125 can be communicated with the storage container 400, and the storage container 400 can be a bottle or a bag, for example, the storage container 400 is a biological salt water bag. When the medicine split charging system 100 is used for split charging medicines, the second pipeline 125 is communicated with the storage container 400, the radiopharmaceuticals in the medicine storage part 200 flow into the split charging container 300 along the first medicine conveying part 11, the first pipeline 124 and the multi-way part 12, and meanwhile, the physiological saline in the physiological saline bag flows into the split charging container 300 along the second pipeline 125 and the multi-way part 12, and the physiological saline is mixed with the radiopharmaceuticals flowing into the split charging container 300, so that the effect of diluting the radiopharmaceuticals is achieved.

In some embodiments of the present utility model, as shown in fig. 2 and 3, the racking device 20 may include: the first sub-packaging mechanism 21, the first sub-packaging mechanism 21 may have a first housing 211 and a first driving assembly, the first driving assembly may be disposed on the first housing 211, and the first driving assembly is connected with the first drug delivery member 11, and the first driving assembly is used for driving the first drug delivery member 11 to move, so that the first drug delivery member 11 is inserted into or pulled out of the drug storage member 200. Specifically, as shown in fig. 2, the first medicine delivery member 11 is disposed outside the first housing 211, the medicine storage member 200 may be disposed in the first housing 211 and exposed out of the first housing 211, when the dispensing device 20 is disposed in the direction of fig. 2, the medicine storage member 200 is located below the first medicine delivery member 11, the first driving assembly may drive the first medicine delivery member 11 to move downward to insert the first medicine delivery member 11 into the medicine storage member 200, and the first driving assembly may also drive the first medicine delivery member 11 to move upward to pull the first medicine delivery member 11 out of the medicine storage member 200, thereby achieving the effect of automatically driving the first medicine delivery member 11 to insert or pull out the medicine storage member 200.

In some embodiments of the present utility model, as shown in fig. 2-4, the first drive assembly may include: the movable seat 213 and the first driving member are in transmission connection with the movable seat 213 to drive the movable seat 213 to move relative to the first housing 211, and further, the movable seat 213 is disposed outside the first housing 211 and movably disposed on the first housing 211, and when the dispensing device 20 is placed in the direction of fig. 2, the movable seat 213 can move along the first housing 211 in the up-down direction. The first driving member is disposed in the first housing 211, and the first driving member may include a linear motor and a ball screw pair, wherein the ball screw pair is in transmission connection between the linear motor and the moving seat 213, and the ball screw pair may drive the moving seat 213 to move up and down along the first housing 211 when the linear motor is operated. Further, as shown in fig. 3, the first housing 211 may be provided with a bar-shaped guide hole 217, the guide hole 217 may extend in the up-down direction of the first housing 211, a part of the structure of the first driving member may pass through the guide hole 217, or a part of the structure of the moving seat 213 may pass through the guide hole 217, and by providing the guide hole 217, it may be ensured that the moving seat 213 moves in the up-down direction of the first housing 211 when the moving seat 213 moves.

Further, the drug delivery assembly 10 may further comprise a mounting plate 13, the mounting plate 13 may be a flat plate structure, the first drug delivery member 11 is mounted on the mounting plate 13, and the mounting plate 13 is detachably mounted on the movable seat 213. Wherein, can be provided with the first mounting hole that is used for installing first medicine delivery piece 11 on the mounting panel 13, first mounting hole runs through mounting panel 13, first medicine delivery piece 11 wears to establish in first mounting hole, first medicine delivery piece 11 fixed mounting is in first mounting hole, when using medicine partial shipment system 100 partial shipment medicine, install mounting panel 13 in moving seat 213, when first driver drive moves seat 213 along first casing 211 up-and-down direction, it moves along first casing 211 to move seat 213 together to drive mounting panel 13, because first medicine delivery piece 11 fixed mounting is at mounting panel 13, mounting panel 13 drives first medicine delivery piece 11 along first casing 211 up-and-down direction removal, realize driving first medicine delivery piece 11 insert or extract medicine storage piece 200 effect. After completion of the dispensing of the medicine, the mounting plate 13 may be detached from the movable seat 213.

Further, when the split charging device 20 is placed in the direction of fig. 2, the moving seat 213 may be disposed above the medicine storage member 200, and the moving seat 213 is disposed opposite to the medicine storage member 200, and after the mounting plate 13 is mounted on the moving seat 213, the moving seat 213 is convenient for driving the first medicine delivery member 11 to insert into or extract from the medicine storage member 200 when moving along the vertical direction of the first housing 211, and also can ensure that the moving seat 213 drives the first medicine delivery member 11 to insert into or extract from the medicine storage member 200 when moving along the vertical direction of the first housing 211.

In some embodiments of the present utility model, as shown in fig. 2 and 3, the first housing 211 may be constructed in an L-shaped structure, a vertical section of which is used to mount the moving seat 213 and the first driving member, and a horizontal section of which is used to assemble the medicine storage member 200.

In some embodiments of the present utility model, as shown in fig. 3 and 4, the movable seat 213 has a slot 215, and the mounting plate 13 is mounted in the slot 215. The mounting board 13 may be inserted into the slot 215 from the open end of the slot 215, so that the mounting board 13 is mounted in the slot 215, and the mounting board 13 may also be pulled out of the slot 215 from the open end of the slot 215, so as to realize the effect that the mounting board 13 is detachably mounted on the movable seat 213.

Further, as shown in fig. 3, the movable seat 213 has a slot 215 therein, and one end of the slot 215 is disposed in an open manner, for example: the upper end or the lower end or the front end or the left end or the right end of the slot 215 may be opened, and the front end of the slot 215 is illustrated as an example. The mounting plate 13 is inserted into the slot 215 from the front end of the slot 215, so that the mounting plate 13 is conveniently mounted in the slot 215, and after the mounting plate 13 is mounted in the slot 215, the bottom wall and the side wall of the slot 215 can limit the mounting plate 13, so that the mounting plate 13 can be reliably mounted in the slot 215.

Further, a first notch 218 may be provided on a side wall (e.g., a left side wall, a right side wall, an upper side wall, or a lower side wall) of the slot 215, which is described in this application by taking a case that the lower side wall of the slot 215 is provided with the first notch 218 communicated with the slot 215 as an example, after the mounting plate 13 is mounted in the slot 215, the first medicine delivery member 11 is inserted into the first notch 218, so as to avoid interference between the first medicine delivery member 11 and the movable seat 213, thereby facilitating insertion or extraction of the first medicine delivery member 11 into or from the medicine storage member 200, and simplifying the structure of the first dispensing mechanism 21.

Further, as shown in fig. 2, a side wall (for example, a left side wall, a right side wall, an upper side wall, or a lower side wall) of the slot 215 is provided with a second notch 219 communicated with the slot 215, and in this application, the upper side wall of the slot 215 is provided with the second notch 219 communicated with the slot 215, and since the first pipeline 124 is connected with the upper end of the first drug delivery member 11, after the mounting plate 13 is mounted in the slot 215, the first pipeline 124 is inserted into the second notch 219, so as to avoid interference between the first pipeline 124 and the movable seat 213.

In some embodiments of the present utility model, the inner side walls of the slot 215 may be provided with a limiting member for stopping against the mounting plate 13, and the limiting member may be a limiting post, a spring ball or a step surface, which is described herein by taking the example that two opposite inner side walls of the slot 215 are provided with spring balls. After the mounting plate 13 is mounted in the slot 215, the spring ball can abut against the mounting plate 13 to prevent the mounting plate 13 from shaking.

In some embodiments of the present utility model, a limiting portion may be disposed on the mounting plate 13, where the limiting portion may be a limiting post, a spring ball, or a step surface, and after the mounting plate 13 is mounted in the slot 215, the limiting portion abuts against an inner side wall of the slot 215 to prevent the mounting plate 13 from shaking.

In some embodiments of the present utility model, as shown in fig. 2-4, the drug delivery assembly 10 may further comprise: the air pressure balance member 14, the air pressure balance member 14 may be configured as a hollow tubular structure, the air pressure balance member 14 may be provided as a pin, and the length of the air pressure balance member 14 is smaller than the length of the first drug delivery member 11. The present utility model is not limited thereto and the air pressure balance 14 may be provided as an air pressure balance valve. The air pressure balance member 14 is disposed on the mounting plate 13, and the air pressure balance member 14 is adapted to be inserted into or pulled out of the medicine storage member 200, and the air pressure balance member 14 is used for communicating the medicine storage member 200 with the external atmospheric pressure. Further, a second mounting hole for mounting the air pressure balancing piece 14 may be provided on the mounting plate 13, the second mounting hole penetrates through the mounting plate 13, the air pressure balancing piece 14 penetrates through the second mounting hole, and the air pressure balancing piece 14 is fixedly mounted in the second mounting hole.

When the medicine split charging system 100 is used for split charging medicines, the mounting plate 13 is mounted on the movable seat 213, and when the movable seat 213 is driven to move along the up-and-down direction of the first housing 211, the movable seat 213 drives the mounting plate 13 to move along the up-and-down direction of the first housing 211, and as the first medicine conveying member 11 and the air pressure balancing member 14 are fixedly mounted on the mounting plate 13, the mounting plate 13 drives the first medicine conveying member 11 and the air pressure balancing member 14 to move along the up-and-down direction of the first housing 211, so that the effect of driving the first medicine conveying member 11 and the air pressure balancing member 14 to be inserted into or pulled out of the medicine storage member 200 is achieved. When the air pressure balance piece 14 is inserted into the medicine storage piece 200, the insertion end of the air pressure balance piece 14 is positioned above the medicine in the medicine storage piece 200, namely, the insertion end of the air pressure balance piece 14 is not inserted into the medicine, and when the first medicine conveying piece 11 extracts the medicine liquid in the medicine storage piece 200, the air pressure in the medicine storage piece 200 is balanced with the external atmospheric pressure through the air pressure balance piece 14, so that negative pressure in the medicine storage piece 200 due to liquid suction is prevented.

In some embodiments of the present utility model, as shown in fig. 2 to 4, the mounting plate 13 is provided with a filter member 15 in communication with the air pressure balance member 14, the filter member 15 may be provided as a filtering membrane, and the filter member 15 may be provided as a filtering valve, but the present utility model is not limited thereto, and the filter member 15 may be provided as other parts having a filtering function. Wherein, the filter element 15 is disposed corresponding to the end of the air pressure balance element 14 away from the medicine storage element 200, i.e. when the mounting plate 13 is placed in the direction shown in fig. 8, the filter element 15 is connected to the upper end of the air pressure balance element 14. Because the liquid medicine in the medicine storage piece 200 has radioactivity, when the air pressure balance piece 14 balances the air pressure in the medicine storage piece 200 and the external atmospheric pressure, the external air flows into the medicine storage piece 200, and through the arrangement of the filter piece 15, the impurity in the external air of the medicine storage piece 200 can be filtered out by the filter piece 15, so that the impurity in the external air of the medicine storage piece 200 is prevented from flowing into the medicine storage piece 200 to pollute the liquid medicine in the medicine storage piece 200.

In some embodiments of the present utility model, as shown in fig. 3, the first housing 211 has a receiving cavity 216 for receiving the drug storage member 200, the receiving cavity 216 being disposed opposite the first drug delivery member 11. Wherein, the first housing 211 may be configured as an L-shaped structure, the vertical section of the L-shaped structure is used for installing the moving seat 213 and the first driving member, the horizontal section of the L-shaped structure may have a receiving cavity 216, after the installation plate 13 is installed in the slot 215, the first drug delivery member 11 and the air pressure balancing member 14 are all located above the receiving cavity 216, and after the drug storage member 200 is assembled in the receiving cavity 216, the drug storage member 200, the first drug delivery member 11 and the air pressure balancing member 14 are all right opposite to each other, so as to ensure that the first drug delivery member 11 and the air pressure balancing member 14 can be inserted into the drug storage member 200.

In some embodiments of the present utility model, a first radiation detecting element, which may be a radiation probe, may be disposed in the receiving cavity 216, the first radiation detecting element is configured to measure a radiation value of the radiopharmaceutical, and after the medicine storing element 200 is assembled in the receiving cavity 216, the first radiation detecting element is configured to detect the medicine in the medicine storing element 200, so as to detect the radiation value of the radiopharmaceutical in the medicine storing element 200.

In some embodiments of the present utility model, the heating element and/or the heat dissipating element may be disposed in the accommodating cavity 216, that is, the accommodating cavity 216 may be provided with only the heating element, the accommodating cavity may be provided with only the heat dissipating element, or the accommodating cavity 216 may be provided with both the heating element and the heat dissipating element, which is described herein by taking the accommodating cavity 216 provided with both the heating element and the heat dissipating element as an example. The heating element is a heating plate or a heating rod, and the heat dissipation element can be a heat dissipation fan. When the medicine split charging system 100 is used for split charging medicines, if the medicines in the medicine storage part 200 need to be heated, the heating part works to heat the containing cavity 216, so that the heating effect on the medicines in the medicine storage part 200 is realized, if the medicines in the medicine storage part 200 need to be cooled, the heat dissipation part works to dissipate heat, so that the temperature in the containing cavity 216 is reduced, and the cooling effect on the medicines in the medicine storage part 200 is realized.

In some embodiments of the present utility model, as shown in fig. 2, 9 and 10, the dispensing device 20 may further include: the second split charging mechanism 30, the second split charging mechanism 30 has a second housing 31, a first peristaltic pump 32 and a second peristaltic pump 33, the first peristaltic pump 32 and the second peristaltic pump 33 are all disposed on the outer surface of the second housing 31, the first pipeline 124 is installed in a first extrusion groove 34 of the first peristaltic pump 32, the second pipeline 125 is installed in a second extrusion groove 35 of the second peristaltic pump 33, and the first peristaltic pump 32 and the second peristaltic pump 33 are respectively used for conveying the liquid medicine and the physiological saline by a power source. As shown in fig. 2, when the medicine packaging system 100 is used for packaging medicines, the first peristaltic pump 32 is controlled to rotate, the first peristaltic pump 32 extrudes the first pipeline 124, at this time, the first medicine delivery member 11 sucks the medicine liquid in the medicine storage member 200 into the first pipeline 124, the medicine liquid in the first pipeline 124 flows into the multi-way member 12 along the first pipeline 124, and the medicine liquid in the multi-way member 12 flows into the packaging container 300 through the medicine outlet 123, so as to achieve the effect of driving the medicine liquid in the medicine storage member 200 to flow into the packaging container 300. When the second peristaltic pump 33 rotates, the second peristaltic pump 33 presses the second pipeline 125, and at this time, the normal saline in the storage container 400 is sucked into the multipass member 12 along the second pipeline 125, and the normal saline in the multipass member 12 flows into the packaging container 300 through the drug outlet 123, so that the normal saline in the storage container 400 is driven to flow into the packaging container 300, and the effect of diluting the liquid medicine is achieved.

In some embodiments of the present utility model, as shown in fig. 2, 9 and 10, the second dispensing mechanism 30 may further have a fixing component 36 and a second driving component 37, where the fixing component 36 and the second driving component 37 are both disposed on the second housing 31, the fixing component 36 is used for placing the dispensing container 300, the second driving component 37 is used for placing the multi-pass member 12, and the second driving component 37 is adapted to drive the multi-pass member 12 to move toward or away from the dispensing container 300, so that the medicine outlet 123 may be communicated with the dispensing container 300 or the medicine outlet 123 may be separated from the dispensing container 300.

Wherein, second drive assembly 37 and second drive assembly 37 all can set up in the roof of second casing 31, when using medicine partial shipment system 100 partial shipment medicine, partial shipment container 300 is placed in fixed subassembly 36, fixed subassembly 36 is spacing to partial shipment container 300, make partial shipment container 300 fixed relative second casing 31 position, the multipass piece 12 is placed on second drive assembly 37, second drive assembly 37 can drive multipass piece 12 and move towards partial shipment container 300, make the exit slot 123 of multipass piece 12 dock with the import of partial shipment container 300, guarantee that the liquid medicine in the multipass piece 12 can flow into partial shipment container 300. After dispensing, the second drive assembly 37 may drive the multi-way member 12 to move in a direction away from the dispensing container 300 such that the drug outlet 123 of the multi-way member 12 is separated from the inlet of the dispensing container 300, and the operator may then take the dispensing container 300 to the patient's room in need of the injection of the radiopharmaceutical.

In some embodiments of the present utility model, as shown in fig. 10 and 11, the second driving assembly 37 may include: the mounting base 371 and the second driving piece, the mounting base 371 has the fixed slot 373 that is used for installing the multichannel piece 12, and the mounting base 371 is connected with the second driving piece transmission, and the second driving piece is suitable for driving the mounting base 371 to move towards or keep away from the partial shipment container 300.

Specifically, as shown in fig. 11, the second driving member is disposed in the second housing 31, where the second driving member may include a driving motor 374, a screw 375, and a slider 376, where the screw 375 is fixedly connected to an output shaft of the driving motor 374, and the slider 376 is sleeved outside the screw 375 and is in threaded fit with the screw 375. The mount 371 is disposed outside the second housing 31, the second housing 31 is provided with a bar-shaped avoidance hole for avoiding the slider 376, and the slider 376 is disposed through the avoidance hole and is fixedly connected with the mount 371. When the medicine split charging system 100 is used for split charging medicines, the multi-way piece 12 is arranged in the fixed groove 373, the driving motor 374 drives the screw 375 to rotate, the driving sliding block 376 moves along the axial direction of the screw 375 when the screw 375 rotates, and the sliding block 376 drives the mounting seat 371 to move together when moving, so that the effect that the second driving piece drives the mounting seat 371 to move towards or away from the split charging container 300 is achieved.

In some embodiments of the present utility model, as shown in fig. 11-14, the securing assembly 36 may include: a shielding case 361 and a fixing block 362, the shielding case 361 defining a shielding space 363 for accommodating the sub-mount container 300, and the shielding case 361 having a first through hole 364 communicating with the shielding space 363. The fixed block 362 has a placement groove 365 for placing the shielding case 361, the fixed block 362 further has a mounting groove 366, and a second radiation detecting element, which may be a radiation probe, is disposed in the mounting groove 366, and the second radiation detecting element is used for measuring a radiation value of the radiopharmaceutical in the dispensing container 300, for example, the second radiation detecting element measures an activity of the radiopharmaceutical in the dispensing container 300, and the first through hole 364 communicates with the mounting groove 366 and the shielding space 363 when the shielding case 361 is placed in the placement groove 365.

Specifically, the packaging container 300 is installed in the shielding space 363 of the shielding shell 361, the shielding shell 361 reduces the radioactive radiation of the medicine in the packaging process, the shielding shell 361 and the packaging container 300 are detachably fixed, the shielding shell 361 and the packaging container 300 can be taken away or fixed together, the inlet of the packaging container 300 is exposed out of the shielding shell 361, the shielding shell 361 is placed in the placing groove 365, the shielding shell 361 is fixedly placed on the fixing block 362, when the shielding shell 361 is placed in the placing groove 365, the first through hole 364 is opposite to the open end of the mounting groove 366, the first through hole 364 is communicated with the mounting groove 366 and the shielding space 363, and after the medicine liquid and the normal saline flow into the packaging container 300, the second radioactive detection element can measure the radioactive value of the radioactive medicine in the packaging container 300.

Further, the fixing block 362 may include a first sub-fixing block 3621 and a second sub-fixing block 3622, where the first sub-fixing block 3621 is fixedly installed above the second sub-fixing block 3622, the second sub-fixing block 3622 defines a mounting slot 366, a second radioactivity detecting element is disposed in the mounting slot 366, and further, a mounting block is disposed in the mounting slot 366, and the second radioactivity detecting element is fixedly installed on the mounting block. The first sub-fixing block 3621 defines a placement groove 365, a second through hole 3623 is formed in the bottom wall of the placement groove 365, the second through hole 3623 is communicated with the mounting groove 366 and the placement groove 365, and when the shielding shell 361 is placed in the placement groove 365, the second through hole 3623 is communicated with the first through hole 364 and the mounting groove 366, so that the second radioactivity detecting element can measure the radioactivity value of the radiopharmaceuticals in the split charging container 300.

Further, the shield case 361 is provided with a rotation cover 369 fixed to rotate, and after the sub-container 300 is mounted in the shield space 363 of the shield case 361, the rotation cover 369 is rotated to clamp the outer edge of the sub-container 300 between the rotation cover 369 and the shield case 361.

In some embodiments of the present utility model, as shown in fig. 13, the open end of the first through hole 364 and/or the mounting slot 366 is provided with lead glass 368, that is, the first through hole 364 is provided with lead glass 368, or the open end of the mounting slot 366 is provided with lead glass 368, or both the first through hole 364 and the open end of the mounting slot 366 are provided with lead glass 368, which is described herein by taking the example that the first through hole 364 is provided with lead glass 368. Wherein the lead glass 368 is transparent, the lead glass 368 can shield a part of the radioactive dose, the radioactive value of the second radioactive detection member measured by the lead glass 368 can be converted into the actual radioactive value of the radiopharmaceutical in the dispensing container 300 according to a certain proportion, and the radiation dose when the shielding shell 361 and the medicine in the dispensing container 300 are moved is reduced by arranging the lead glass 368. The dispensing container 300 may be provided as a syringe.

It should be noted that, the rotation speeds of the first peristaltic pump 32 and the second peristaltic pump 33 may be set according to actual requirements, and the rotation speeds of the first peristaltic pump 32 and the second peristaltic pump 33 may be different, and in general, the rotation speed of the second peristaltic pump 33 is fast. I.e. the second peristaltic pump 33 delivering saline, rotates slightly faster. Because the peristaltic pump with a fast rotation speed fills the corresponding delivery pipeline, when the radiopharmaceutical stock solution reaches the packaging container 300, the second radioactivity detecting element detects the radioactivity value of the medicinal solution in the packaging container 300, the peristaltic pump is controlled to rotate by a program, the range of the radioactivity value is manually set, for example, 1mCi is set, and when the value detected by the second radioactivity detecting element reaches 1mCi, the first peristaltic pump 32 and the second peristaltic pump 33 stop running. At this time, the first line 124 is filled with the liquid medicine, and the second line 125 is filled with the physiological saline.

Then, the sub-container 300 containing the liquid medicine can be removed from the fixing block 362, a new sub-container 300 is placed on the fixing block 362, and when the sub-container 300 is replaced, the second driving assembly 37 drives the multi-way member 12 to be far away from the sub-container 300, so that the sub-container 300 is convenient to take out and mount, and after the new sub-container 300 is replaced, the second driving assembly 37 drives the multi-way member 12 to move towards the sub-container 300, so that the sub-container 300 is in plug-in connection with the multi-way member 12. The racking procedure is then performed. When the medicine storage member 200 is placed, the activity and the volume of the medicine liquid input into the main interface of the dispensing device 20 are dispensed according to the required activity. For example, the nuclide concentration is 10mCi/mL, and the required activity is 10mCi, and the volume is 3mL. The rotating speed of peristaltic pump corresponding to normal saline and radioactive drug stock solution is 2:1, the peristaltic pump of physiological saline is 2mL/min, the radiopharmaceuticals are 1mL/min, and the first peristaltic pump 32 and the second peristaltic pump 33 are operated simultaneously, namely after 1min, the volume of the liquid medicine in the split charging container 300 is 3mL, and the activity of the liquid medicine is 10mCi. If the input activity is 10mCi, the activity of the liquid medicine in the medicine storage member 200 is less than 10mCi, and a prompt dialog box is displayed, so that the prompt activity is insufficient. The whole process is provided with a progress bar prompt. Wherein the speed ratio between the first peristaltic pump 32 and the second peristaltic pump 33 is calculated from the input initial activity and initial volume of radioactive stock solution.

In some embodiments of the present utility model, as shown in fig. 1, the medicament dispensing system 100 may further include: a synthesis device 40, the synthesis device 40 being for synthesizing a radiopharmaceutical, and the synthesis device 40 being adapted to deliver the radiopharmaceutical into a drug reservoir 200. Wherein, the synthesizing device 40 is communicated with the drug storage part 200 through the third pipeline 50, and after the synthesizing device 40 synthesizes the radiopharmaceuticals, the radiopharmaceuticals in the synthesizing device 40 can flow into the drug storage part 200 along the third pipeline 50.

In some embodiments of the present utility model, as shown in fig. 1 and 22, the synthesizing apparatus 40 may include a shower bottle 41, a nuclide generator 42, a three-way valve 43, and a syringe 44, and the syringe 44 may have the same structure as the dispensing container 300. The three-way valve 43 has a first valve port 431, a second valve port 432 and a third valve port 433, the first valve port 431 being in communication with the rinse bottle 41, the second valve port 432 being in communication with the syringe 44, the third valve port 433 being in communication with the generator inlet 421 of the nuclide generator 42, the generator outlet 422 of the nuclide generator 42 being adapted to be in communication with the drug reservoir 200.

Specifically, the first valve port 431 communicates with the rinse bottle 41 through the fourth line 60, the third valve port 433 communicates with the generator inlet 421 of the nuclide generator 42 through the fifth line 70, and the generator outlet 422 of the nuclide generator 42 communicates with the drug reservoir 200 through the third line 50. When the radioactive drug is synthesized, the drug storage piece 200 containing the drug precursor of the nuclide to be marked is placed in the accommodating cavity 216, the first valve port 431 is controlled to be communicated with the second valve port 432, the syringe piston 441 of the syringe 44 is controlled to move to suck the hydrochloric acid solution in the leaching bottle 41 into the syringe 44, then the second valve port 432 is controlled to be communicated with the third valve port 433, and the syringe piston 441 of the syringe 44 is controlled to move to transfer the hydrochloric acid solution in the syringe 44 to the drug storage piece 200 through the nuclide generator 42, so that the nuclide is leached.

It should be noted that, the three-way valve 43 may be driven by a steering engine (a rotating motor) of the three-way valve 43 to rotate to realize conversion of different liquid flow directions. The product bottle (i.e., drug storage 200) is heated to a desired synthesis temperature by the heating element prior to the leaching of the nuclide, and after the nuclide is leached, the synthesis label reacts for a period of time to form the desired radiopharmaceutical. The synthesis work is stopped after the synthesis of the radiopharmaceutical. After the synthesis work is stopped, the split charging work can be performed.

In some embodiments of the present utility model, as shown in fig. 22 and 24, the synthesizing apparatus 40 may further include: a third housing 45 and a third driving assembly 46, the third driving assembly 46 is disposed on the third housing 45, and the third driving assembly 46 is connected with the syringe piston 441 of the syringe 44 to drive the syringe piston 441 to move. Further, as shown in fig. 22, the third driving assembly 46 may include a driving block 461 and a motor, the driving block 461 is disposed outside the third housing 45, the motor is disposed in the third housing 45, an output shaft of the motor is connected with a screw 462, a screw 463 may be disposed on the screw 462, the screw 463 is sleeved on the screw 462 and is in threaded fit connection with the screw 462, the screw 463 is fixedly connected with the driving block 461, and the syringe piston 441 of the syringe 44 is mounted on the driving block 461. When the motor works, the motor drives the screw 462 to rotate, and when the screw 462 rotates, the driving screw 463 drives the driving block 461 to move, so that the driving block 461 drives the syringe piston 441 of the syringe 44 to move along the axial direction of the syringe 44, and the effects of liquid pumping and liquid discharging of the syringe 44 are realized.

In some embodiments of the present utility model, the drug delivery assembly 10 is removably mounted to the dispensing device 20, and after the drug delivery assembly 10 is used, the used drug delivery assembly 10 may be removed from the dispensing device 20, and a new drug delivery assembly 10 may be mounted to the dispensing device 20 for use next time.

As shown in fig. 5, a schematic view of a first embodiment of a drug delivery assembly 10, as shown in fig. 6, a schematic view of a second embodiment of a drug delivery assembly 10. The drug delivery assembly 10 of the second embodiment differs from the drug delivery assembly 10 of the first embodiment in that: the first pipeline 124 is provided with two limiting blocks 16, a pipeline section between the two limiting blocks 16 is installed in the first extrusion groove 34 of the first peristaltic pump 32, and the limiting blocks 16 are in limiting fit with the first peristaltic pump 32 to prevent the first pipeline 124 from moving in the first extrusion groove 34. Similarly, two limiting blocks 16 may be disposed on the first pipeline 124, which is not described in detail herein. The limiting block 16 can be a boss externally connected to the outer wall of the pipeline, or a joint.

It should be noted that, through designing tee joint's multipass part 12, will be should two steps of partial shipment process reduction to one step of operations (draw radiopharmaceutical and diluted normal saline to dilute simultaneously and mix, carry out partial shipment then), save time, avoided the installation disorder between the different pipelines, only need once install then follow-up need not to go the operation again through the manual work, reduce the contact of radioactive radiation. In addition, the medicine split charging system 100 realizes the synthesis and split charging of the full-automatic radioactive medicine, is convenient and quick, and greatly reduces the contact time of operators.

In the description of the present specification, reference to the terms "one embodiment," "some embodiments," "illustrative embodiments," "examples," "specific examples," or "some examples," etc., means that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the utility model. In this specification, schematic representations of the above terms do not necessarily refer to the same embodiments or examples. Furthermore, the particular features, structures, materials, or characteristics described may be combined in any suitable manner in any one or more embodiments or examples.

While embodiments of the present utility model have been shown and described, it will be understood by those of ordinary skill in the art that: many changes, modifications, substitutions and variations may be made to the embodiments without departing from the spirit and principles of the utility model, the scope of which is defined by the claims and their equivalents.

Claims

1. A medicament dispensing system, comprising:

2. The drug dispensing system of claim 1, wherein the manifold has a first drug inlet, a second drug inlet, and a drug outlet, the drug outlet is in communication with both the first drug inlet and the second drug inlet, the first drug inlet is in communication with the first drug delivery member via a first conduit, and the second drug inlet is in communication with a second conduit.

3. The drug dispensing system of claim 2, wherein the dispensing device comprises: the first split charging mechanism is provided with a first shell and a first driving assembly, the first driving assembly is arranged on the first shell and is connected with the first medicine conveying piece, and the first driving assembly is used for driving the first medicine conveying piece to move so that the first medicine conveying piece can be inserted into or pulled out of the medicine storage piece.

4. A medicament dispensing system as recited in claim 3, wherein said first drive assembly comprises: remove seat and first driving piece, first driving piece with remove seat transmission connection with the drive remove the seat relative first casing removes, drug delivery assembly still includes the mounting panel, first drug delivery piece install in the mounting panel, mounting panel detachably install in remove the seat.

5. The medication dispensing system of claim 4 wherein said mobile station has a slot, said mounting plate being mounted within said slot.

6. The medication dispensing system of claim 5 wherein said slot has an inner sidewall with a stop for stopping said mounting plate.

7. The drug dispensing system of claim 4, wherein the drug delivery assembly further comprises an air pressure balance member disposed on the mounting plate and adapted to be inserted into or withdrawn from the drug storage member, the air pressure balance member being adapted to communicate the drug storage member with an external atmosphere.

8. The drug dispensing system of claim 7, wherein the mounting plate is provided with a filter in communication with the pneumatic balance.

9. A medicament dispensing system as recited in claim 3, wherein said first housing has a receiving cavity for receiving said medicament storage member, said receiving cavity being opposite said first medicament delivery member.

10. The drug dispensing system of claim 9, wherein the receiving cavity is provided with a first radiation detecting member.

11. A medicament dispensing system according to claim 9, wherein the receiving chamber is provided with heating means and/or heat dissipating means.

12. A medicament dispensing system as recited in claim 3, wherein said dispensing apparatus further comprises: the second split charging mechanism is provided with a second shell, a first peristaltic pump and a second peristaltic pump, the first peristaltic pump and the second peristaltic pump are arranged on the outer surface of the second shell, the first pipeline is arranged in a first extrusion groove of the first peristaltic pump, and the second pipeline is arranged in a second extrusion groove of the second peristaltic pump.

13. The drug dispensing system of claim 12, wherein the second dispensing mechanism further has a fixed assembly and a second drive assembly, both of which are provided to the second housing, the fixed assembly being for placing the dispensing container, the second drive assembly being for placing the multipass member, the second drive assembly being adapted to drive the multipass member toward or away from the dispensing container to communicate the drug outlet with the dispensing container or separate the drug outlet from the dispensing container.

14. The drug dispensing system of claim 13, wherein the second drive assembly comprises: the mounting seat is provided with a fixing groove for mounting the multi-way part, the mounting seat is in transmission connection with the second driving part, and the second driving part is suitable for driving the mounting seat to move towards or away from the sub-packaging container.

15. The drug dispensing system of claim 13, wherein the securing assembly comprises: a shielding shell and a fixed block, wherein the shielding shell defines a shielding space for accommodating the sub-packaging container, and the shielding shell is provided with a first through hole communicated with the shielding space;

16. The medicament dispensing system of claim 15, wherein the first through hole and/or the open end of the mounting slot is provided with lead glass.

17. The medicament dispensing system of any of claims 1-16, further comprising: a synthesis device for synthesizing a radiopharmaceutical and adapted to deliver the radiopharmaceutical into the drug reservoir.

18. The drug dispensing system of claim 17, wherein the synthesizing device comprises a rinse bottle, a nuclide generator, a three-way valve, and a syringe, the three-way valve having a first valve port, a second valve port, and a third valve port, the first valve port in communication with the rinse bottle, the second valve port in communication with the syringe, the third valve port in communication with a generator inlet of the nuclide generator, and a generator outlet of the nuclide generator adapted to communicate with the drug storage.

19. The drug dispensing system of claim 18, wherein the synthesizing device further comprises: the third driving assembly is arranged on the third shell and connected with the syringe piston of the syringe to drive the syringe piston to move.